ReCode Therapeutics, a clinical-stage genetic medicines company pioneering tissue-specific delivery technologies to advance the next generation of mRNA and gene correction therapeutics, announced today that it has secured more than $29 million in new financing. Alongside this financial update, the…
Amplitude Vascular Systems (AVS), a medical device company pioneering solutions to safely and effectively treat severely calcified arterial disease, today announced the opening of its new global headquarters at 180 Third Avenue in Waltham, Massachusetts. The state-of-the-art facility spans 37,811…
Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, announced today two major milestones that significantly advance its lead gene therapy program for dysferlinopathy, a rare and debilitating neuromuscular disease. The company has secured a commitment of…
Immuto Scientific today announced the closing of an oversubscribed $8 million Seed 2 financing round alongside a new drug discovery collaboration with Daiichi Sankyo, a leading global pharmaceutical company. The funding and collaboration represent significant milestones for Immuto as it…
Echo Receives 2025 Global Recognition Award for Innovation in Hydrogen Water Technology Echo, a leader in wellness and hydration technology, has been honored with a 2025 Global Recognition Award™, a distinction that acknowledges the company’s pioneering role in hydrogen water…
Impulse Space, a U.S.-based leader in in-space transportation, and Infinite Orbits, a France-based company specializing in in-orbit services, have expanded their collaboration by signing a new multi-launch agreement. The deal will deliver multiple Infinite Orbits spacecraft to geostationary orbit (GEO)…
Merck, a leading science and technology company, continues its organic growth. Despite ongoing geopolitical uncertainties, Group net sales in the second quarter of 2025 increased by 2.0% organically compared with the year-earlier quarter, while EBITDA pre rose by 4.6% organically.…
Orbia Reports Second Quarter 2025 Financial Results: Navigating Challenges, Focusing on Operational Discipline and Strategic Growth Orbia has reported its financial results for the second quarter of 2025, delivering total revenues of $1.97 billion and EBITDA of $300 million amid…
Renasant Bio Launches with $54.5M to Advance Next-Generation Therapies for ADPKD Renasant Bio (Renasant) today announced its official launch with a bold mission: to pioneer next-generation, disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD)—the most common inherited cause of…
NYB.AI and Pnaseer Form Strategic Alliance to Advance AI-Powered Hair Regeneration Research NYB.AI, a pioneer in AI-driven drug discovery, and Pnaseer Inc., a leader in bio-nanoparticle drug delivery technologies, have announced a strategic partnership to accelerate the discovery and development…
H2SITE Secures EIC Accelerator Funding to Deploy Groundbreaking Ammonia Cracker at Northwest European Port H2SITE has been selected for funding by the European Innovation Council (EIC) Accelerator program to support the deployment of a pioneering ammonia cracking unit capable of…
PPG and ArcelorMittal Advance Low-Carbon Automotive Manufacturing PPG and ArcelorMittal, a global leader in steel production, have unveiled a major milestone in their shared mission to reduce carbon emissions in the automotive manufacturing sector. The two industry giants are collaborating…